Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP357743.RAyIcHrdgVA5lJ-ch48olZqhTHmchLH5xZ2a87oxtQV4g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP357743.RAyIcHrdgVA5lJ-ch48olZqhTHmchLH5xZ2a87oxtQV4g130_assertion type Assertion NP357743.RAyIcHrdgVA5lJ-ch48olZqhTHmchLH5xZ2a87oxtQV4g130_head.
- NP357743.RAyIcHrdgVA5lJ-ch48olZqhTHmchLH5xZ2a87oxtQV4g130_assertion description "[Aberrant differentiation in MDS can often be traced to abnormal DNA methylation (both gains and losses of DNA methylation genome wide and at specific loci) as well as mutations in genes that regulate epigenetic programs (TET2 and DNMT3a, both involved in DNA methylation control; EZH2 and ASXL1, both involved in histone methylation control).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP357743.RAyIcHrdgVA5lJ-ch48olZqhTHmchLH5xZ2a87oxtQV4g130_provenance.
- NP357743.RAyIcHrdgVA5lJ-ch48olZqhTHmchLH5xZ2a87oxtQV4g130_assertion evidence source_evidence_literature NP357743.RAyIcHrdgVA5lJ-ch48olZqhTHmchLH5xZ2a87oxtQV4g130_provenance.
- NP357743.RAyIcHrdgVA5lJ-ch48olZqhTHmchLH5xZ2a87oxtQV4g130_assertion SIO_000772 23660859 NP357743.RAyIcHrdgVA5lJ-ch48olZqhTHmchLH5xZ2a87oxtQV4g130_provenance.
- NP357743.RAyIcHrdgVA5lJ-ch48olZqhTHmchLH5xZ2a87oxtQV4g130_assertion wasDerivedFrom befree-20150227 NP357743.RAyIcHrdgVA5lJ-ch48olZqhTHmchLH5xZ2a87oxtQV4g130_provenance.
- NP357743.RAyIcHrdgVA5lJ-ch48olZqhTHmchLH5xZ2a87oxtQV4g130_assertion wasGeneratedBy ECO_0000203 NP357743.RAyIcHrdgVA5lJ-ch48olZqhTHmchLH5xZ2a87oxtQV4g130_provenance.